Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell properties and epithelial malignancies.

Ian C Mackenzie1

  • 1Center for Cutaneous Biology, Institute for Cell and Molecular Science, 4 Newark Street, Whitechapel, London E1 2AT, UK. i.c.mackenzie@qmul.ac.uk

European Journal of Cancer (Oxford, England : 1990)
|April 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A CD24<sup>+</sup>CD271<sup>+</sup> melanoma cancer stem cell possesses hybrid characteristics of its single marker counterparts and promotes invasion and therapeutic resistance.

BMC biology·2025
Same author

Disseminating cells in human oral tumours possess an EMT cancer stem cell marker profile that is predictive of metastasis in image-based machine learning.

eLife·2023
Same author

Embryonic Stem Cells Can Generate Oral Epithelia under Matrix Instruction.

International journal of molecular sciences·2023
Same author

Supramolecular Presentation of Hyaluronan onto Model Surfaces for Studying the Behavior of Cancer Stem Cells.

Advanced biosystems·2020
Same author

Effects of Cetuximab and Erlotinib on the behaviour of cancer stem cells in head and neck squamous cell carcinoma.

Oncotarget·2018
Same author

Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma.

EBioMedicine·2016
Same journal

Early-onset colorectal cancer across Europe: Burden, mechanisms, and health-system implications.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinical urgency of incidental findings in the first year of the 4-IN-THE-LUNG-RUN lung cancer screening program.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

European journal of cancer (Oxford, England : 1990)·2026
See all related articles

Normal tissue growth relies on somatic stem cells. Tumors also contain similar cancer stem cells, which are key therapeutic targets, though their precise role in treatment response needs further study.

Area of Science:

  • Stem cell biology
  • Cancer research
  • Tissue regeneration

Background:

  • Somatic stem cells are crucial for normal tissue growth and repair, possessing indefinite self-renewal capabilities.
  • Tumor growth, similar to normal tissues, is driven by a subpopulation of cancer stem cells.
  • Tumor-initiating cells with distinct surface phenotypes have been identified in both leukemias and solid tumors.

Purpose of the Study:

  • To investigate the role of cancer stem cells in tumor growth and their potential as therapeutic targets.
  • To explore the similarities between normal stem cell hierarchies and patterns observed in tumor cell lines.
  • To understand how differences between malignant stem cells and other tumor cells impact therapeutic outcomes.

Main Methods:

  • Isolation of phenotypically distinct tumor-initiating cell subpopulations.

Related Experiment Videos

  • Analysis of cell surface phenotypes to identify tumor-initiating cells.
  • Characterization of stem cell patterns in tumor cell lines using properties like clonogenic ability, size, adhesiveness, dye exclusion, and gene expression.

    • Main Results:

    • Tumor-initiating subpopulations with distinct cell surface phenotypes were identified in solid tumors.
    • Tumor cell lines retain hierarchical stem cell patterns, evidenced by differing clonogenic abilities and cellular properties.
    • Malignant stem cells are implicated as primary targets for cancer therapy.

    Conclusions:

    • Cancer stem cells are critical drivers of tumor growth and represent a key focus for therapeutic strategies.
    • Further research is needed to clarify how malignant stem cell characteristics influence therapeutic responses.
    • In vitro models of stem cell patterns offer potential for developing novel therapeutic approaches.